Literature DB >> 21088182

Retrospective study of necropsy-associated coagulase-positive staphylococci in horses.

Marisa Haenni1, Hayette Targant, Karine Forest, Corinne Sévin, Jackie Tapprest, Claire Laugier, Jean-Yves Madec.   

Abstract

Coagulase-positive staphylococci (CoPS) are potential causative agents of equine infections, but they are rarely responsible for the death of the animal. In the current study, staphylococci implicated in the death or euthanasia of horses were retrospectively studied in 3,457 necropsies performed over a decade (1995-2006). Morbidity associated with CoPS was 1.7%, representing 60 isolates of CoPS, which were identified as Staphylococcus aureus (59) and Staphylococcus pseudintermedius (1). Coagulase-positive staphylococci (alone or in association with another bacterial species) were associated with the death or euthanasia of 90% of the cases (54/60). Proportions of antibiotic resistance to penicillin G and tetracycline reached 62.7% and 23.7%, respectively. Virulence genes were detected in 91.7% of the strains, with a majority of seh or sei enterotoxin genes. Finally, 3 methicillin-resistant Staphylococcus aureus (MRSA) isolates belonging to the t064 spa-type were identified. One strain was isolated in 2003 and might thus be one of the first cases of equine MRSA in France.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088182     DOI: 10.1177/104063871002200617

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Canine superficial pyoderma and therapeutic considerations.

Authors:  Jangi Bajwa
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

2.  Assessment of animal diseases caused by bacteria resistant to antimicrobials: Horses.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Angel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Stahl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Jeroen Dewulf; Luca Guardabassi; Friederike Hilbert; Rodolphe Mader; Francesca Baldinelli; Julio Alvarez
Journal:  EFSA J       Date:  2021-12-24

3.  Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.

Authors:  Haroon Mohammad; P V Narasimha Reddy; Dennis Monteleone; Abdelrahman S Mayhoub; Mark Cushman; G Kenitra Hammac; Mohamed N Seleem
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

4.  Nationwide molecular epidemiology of methicillin-resistant Staphylococcus aureus responsible for horse infections in France.

Authors:  François Guérin; Marguerite Fines-Guyon; Pierrick Meignen; Géraldine Delente; Caroline Fondrinier; Nancy Bourdon; Vincent Cattoir; Albertine Léon
Journal:  BMC Microbiol       Date:  2017-05-03       Impact factor: 3.605

5.  An epidemiologic study of antimicrobial resistance of Staphylococcus species isolated from equine samples submitted to a diagnostic laboratory.

Authors:  Ronita Adams; Jackie Smith; Stephen Locke; Erica Phillips; Erdal Erol; Craig Carter; Agricola Odoi
Journal:  BMC Vet Res       Date:  2018-02-05       Impact factor: 2.741

6.  Systemic Staphylococcus pseudintermedius infection in an arctic fox (Vulpes lagopus) with severe multifocal suppurative meningoencephalitis and nephritis.

Authors:  Kei Iwata; Kazufumi Kasuya; Kou Takayama; Yusuke Nakahara; Yoshifumi Kobayashi; Asako Kato; Hironobu Senba; Masae Yanagisawa; Tomoyuki Shibahara
Journal:  J Vet Med Sci       Date:  2018-06-11       Impact factor: 1.267

7.  Analysis of Virulence and Antimicrobial Resistance Gene Carriage in Staphylococcus aureus Infections in Equids Using Whole-Genome Sequencing.

Authors:  Sara V Little; Andrew E Hillhouse; Sara D Lawhon; Laura K Bryan
Journal:  mSphere       Date:  2021-08-04       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.